130 related articles for article (PubMed ID: 12716760)
21. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
Lewis GP; Watts IS
Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
[TBL] [Abstract][Full Text] [Related]
22. Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins.
Takahashi Y; Chiba H; Matsuno K; Akita H; Hui SP; Nagasaka H; Nakamura H; Kobayashi K; Tandon NN; Jamieson GA
Biochem Biophys Res Commun; 1996 May; 222(2):453-9. PubMed ID: 8670226
[TBL] [Abstract][Full Text] [Related]
23. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
24. Involvement of activated integrin alpha2beta1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions.
Moroi M; Onitsuka I; Imaizumi T; Jung SM
Thromb Haemost; 2000 May; 83(5):769-76. PubMed ID: 10823276
[TBL] [Abstract][Full Text] [Related]
25. Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways.
Garcia A; Kim S; Bhavaraju K; Schoenwaelder SM; Kunapuli SP
Biochem J; 2010 Jul; 429(2):369-77. PubMed ID: 20441566
[TBL] [Abstract][Full Text] [Related]
26. Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.
Tang WH; Stitham J; Gleim S; Di Febbo C; Porreca E; Fava C; Tacconelli S; Capone M; Evangelista V; Levantesi G; Wen L; Martin K; Minuz P; Rade J; Patrignani P; Hwa J
J Clin Invest; 2011 Nov; 121(11):4462-76. PubMed ID: 22005299
[TBL] [Abstract][Full Text] [Related]
27. Platelet membrane glycoprotein IV (CD36) is involved in arachidonic acid induced-platelet aggregation.
Dutta-Roy AK; Crosbie LC; Gordon MJ; Campbell FM
Biochem Soc Trans; 1996 May; 24(2):167S. PubMed ID: 8736825
[No Abstract] [Full Text] [Related]
28. Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents.
Yamazaki M; Uchiyama S; Xiong Y; Nakano T; Nakamura T; Iwata M
Thromb Res; 2005; 115(3):211-8. PubMed ID: 15617744
[TBL] [Abstract][Full Text] [Related]
29. Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathway.
Wang H; Zhong L; Mi S; Song N; Zhang W; Zhong M
BMC Cardiovasc Disord; 2020 Feb; 20(1):81. PubMed ID: 32059638
[TBL] [Abstract][Full Text] [Related]
30. Differential effect of aspirin on platelet aggregation in IDDM.
Mori TA; Vandongen R; Douglas AJ; McCulloch RK; Burke V
Diabetes; 1992 Mar; 41(3):261-6. PubMed ID: 1551486
[TBL] [Abstract][Full Text] [Related]
31. Modulators of intraplatelet calcium concentration affect the binding of thrombospondin to blood platelets in healthy donors and patients with type 2 diabetes mellitus.
Wieclawska B; Rozalski M; Trojanowski Z; Watala C
Eur J Haematol; 2001 Jun; 66(6):396-403. PubMed ID: 11488939
[TBL] [Abstract][Full Text] [Related]
32. Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease.
Mikhailidis DP; Barradas MA; Maris A; Jeremy JY; Dandona P
J Clin Pathol; 1985 Oct; 38(10):1166-71. PubMed ID: 3902901
[TBL] [Abstract][Full Text] [Related]
33. Platelets deficient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V.
Kehrel B; Kronenberg A; Rauterberg J; Niesing-Bresch D; Niehues U; Kardoeus J; Schwippert B; Tschöpe D; van de Loo J; Clemetson KJ
Blood; 1993 Dec; 82(11):3364-70. PubMed ID: 7694682
[TBL] [Abstract][Full Text] [Related]
34. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
35. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
36. Insufficient mobilization of calcium by early breakdown of phosphatidylinositol 4,5-bisphosphate for aggregation of human platelets by collagen.
Narita H; Park HJ; Tanaka K; Matsuura T; Kito M
J Biochem; 1985 Oct; 98(4):1063-8. PubMed ID: 3001036
[TBL] [Abstract][Full Text] [Related]
37. Aggregation of gel-filtered guinea-pig platelets by lipoproteins.
Fujitani B; Tsuboi T; Yoshida K; Shimizu M
Thromb Haemost; 1979 Apr; 41(2):416-24. PubMed ID: 224521
[TBL] [Abstract][Full Text] [Related]
38. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
39. Functional role of NADPH oxidase in activation of platelets.
Chlopicki S; Olszanecki R; Janiszewski M; Laurindo FR; Panz T; Miedzobrodzki J
Antioxid Redox Signal; 2004 Aug; 6(4):691-8. PubMed ID: 15242549
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
